Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice ; year:2021
European journal of immunology ; (2021)
- Urheber
-
Stoycheva, Diana
Sandu, Ioana
Gräbnitz, Fabienne
Amorim, Ana
Borsa, Mariana
Weber, Stefan
Becher, Burkhard
Oxenius, Annette
- DOI
-
10.1002/eji.202049068
- URN
-
urn:nbn:de:101:1-2021022407234148180706
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stoycheva, Diana
- Sandu, Ioana
- Gräbnitz, Fabienne
- Amorim, Ana
- Borsa, Mariana
- Weber, Stefan
- Becher, Burkhard
- Oxenius, Annette
Ähnliche Objekte (12)
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes
Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection
Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Impact of Sleep on Monocytes and Infection
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes
Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection
Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Impact of Sleep on Monocytes and Infection
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes
Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection
Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Impact of Sleep on Monocytes and Infection